PCIG
PFE icon

Partners Capital Investment Group’s Pfizer PFE Stock Holding History

Partners Capital Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,184
Closed -$588K – 74
2015
Q4 		$588K Buy
+19,184
New +$604K 0.2% 37

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Partners Capital Investment Group's PFE Position: Q1 2016 in Review

Partners Capital Investment Group sold out of Pfizer (PFE) in Q1 2016, closing a stake of 19,184 shares — an estimated $588K sold.

Partners Capital Investment Group first reported a position in PFE in Q4 2015 and held it in 1 quarter. The position peaked at $588K in Q4 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Partners Capital Investment Group reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
  • Partners Capital Investment Group sold 19,184 Pfizer shares in Q1 2016, an estimated $588K.
  • Partners Capital Investment Group first reported a position in Pfizer in Q4 2015 and held it in 1 quarter.
  • Partners Capital Investment Group's Pfizer position peaked at $588K in Q4 2015.
  • 1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Partners Capital Investment Group's 13F filing for Q1 2016, filed 11 May 2016.